ALZT-QoL

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug NameALZT-QoL

Drug Alias NameM1-type muscarinic receptor agonist (AZ Therapies)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMuscarinic acetylcholine receptor M1 agonists

TargetsMuscarinic acetylcholine receptor M1

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAztherapies Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAztherapies Inc

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A